{"transactions":[{"id":687917,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-08-13T14:07:24.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\"), Blake Holdings Limited (\"BHL\"), Ora Ventures Limited (\"OVL\"), Ora Capital Limited (\"OCL), Sarossa Plc (\"SAR\"), Pinkeys Limited (\"PKL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL, BHL, OVL and OCL and the controlling shareholder of SAR and PKL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":4797166,"derivative":{"exercise_price":16,"underlying":"Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-26-095574","document":"tm2623118-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926095574/tm2623118-2_4seq1.xml","form_type":"4"}},{"id":687916,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-08-13T14:07:24.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\"), Blake Holdings Limited (\"BHL\"), Ora Ventures Limited (\"OVL\"), Ora Capital Limited (\"OCL), Sarossa Plc (\"SAR\"), Pinkeys Limited (\"PKL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL, BHL, OVL and OCL and the controlling shareholder of SAR and PKL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":4897166,"derivative":{"exercise_price":16.35,"underlying":"Ordinary Shares","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001104659-26-095574","document":"tm2623118-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926095574/tm2623118-2_4seq1.xml","form_type":"4"}},{"id":687915,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-08-13T14:07:24.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":true,"shares":120000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\"), Blake Holdings Limited (\"BHL\"), Ora Ventures Limited (\"OVL\"), Ora Capital Limited (\"OCL), Sarossa Plc (\"SAR\"), Pinkeys Limited (\"PKL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL, BHL, OVL and OCL and the controlling shareholder of SAR and PKL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":4957166,"derivative":{"exercise_price":16,"underlying":"Ordinary Shares","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001104659-26-095574","document":"tm2623118-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926095574/tm2623118-2_4seq1.xml","form_type":"4"}},{"id":687914,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-08-13T14:07:24.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":true,"shares":605174,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\"), Blake Holdings Limited (\"BHL\"), Ora Ventures Limited (\"OVL\"), Ora Capital Limited (\"OCL), Sarossa Plc (\"SAR\"), Pinkeys Limited (\"PKL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL, BHL, OVL and OCL and the controlling shareholder of SAR and PKL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":5077166,"derivative":{"exercise_price":16,"underlying":"Ordinary Shares","underlying_shares":1815522},"source":{"system":"sec-edgar","filing":"0001104659-26-095574","document":"tm2623118-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926095574/tm2623118-2_4seq1.xml","form_type":"4"}},{"id":687913,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-08-13T14:07:24.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":true,"shares":470820,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\"), Blake Holdings Limited (\"BHL\"), Ora Ventures Limited (\"OVL\"), Ora Capital Limited (\"OCL), Sarossa Plc (\"SAR\"), Pinkeys Limited (\"PKL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL, BHL, OVL and OCL and the controlling shareholder of SAR and PKL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":5682340,"derivative":{"exercise_price":16.09,"underlying":"Ordinary Shares","underlying_shares":1412460},"source":{"system":"sec-edgar","filing":"0001104659-26-095574","document":"tm2623118-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926095574/tm2623118-2_4seq1.xml","form_type":"4"}},{"id":687912,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-08-13T14:07:24.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":true,"shares":382000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\"), Blake Holdings Limited (\"BHL\"), Ora Ventures Limited (\"OVL\"), Ora Capital Limited (\"OCL), Sarossa Plc (\"SAR\"), Pinkeys Limited (\"PKL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL, BHL, OVL and OCL and the controlling shareholder of SAR and PKL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":6153160,"derivative":{"exercise_price":16,"underlying":"Ordinary Shares","underlying_shares":1146000},"source":{"system":"sec-edgar","filing":"0001104659-26-095574","document":"tm2623118-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926095574/tm2623118-2_4seq1.xml","form_type":"4"}},{"id":687911,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-08-13T14:07:24.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":true,"shares":800000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\"), Blake Holdings Limited (\"BHL\"), Ora Ventures Limited (\"OVL\"), Ora Capital Limited (\"OCL), Sarossa Plc (\"SAR\"), Pinkeys Limited (\"PKL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL, BHL, OVL and OCL and the controlling shareholder of SAR and PKL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":6535160,"derivative":{"exercise_price":16,"underlying":"Ordinary Shares","underlying_shares":2400000},"source":{"system":"sec-edgar","filing":"0001104659-26-095574","document":"tm2623118-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926095574/tm2623118-2_4seq1.xml","form_type":"4"}},{"id":687910,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-08-13T14:07:24.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":true,"shares":3500,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\"), Blake Holdings Limited (\"BHL\"), Ora Ventures Limited (\"OVL\"), Ora Capital Limited (\"OCL), Sarossa Plc (\"SAR\"), Pinkeys Limited (\"PKL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL, BHL, OVL and OCL and the controlling shareholder of SAR and PKL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":7335160,"derivative":{"exercise_price":16.35,"underlying":"Ordinary Shares","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001104659-26-095574","document":"tm2623118-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926095574/tm2623118-2_4seq1.xml","form_type":"4"}},{"id":687909,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-08-13T14:07:24.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\"), Blake Holdings Limited (\"BHL\"), Ora Ventures Limited (\"OVL\"), Ora Capital Limited (\"OCL), Sarossa Plc (\"SAR\"), Pinkeys Limited (\"PKL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL, BHL, OVL and OCL and the controlling shareholder of SAR and PKL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":7338660,"derivative":{"exercise_price":16.09,"underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-26-095574","document":"tm2623118-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926095574/tm2623118-2_4seq1.xml","form_type":"4"}},{"id":687908,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-08-13T14:07:24.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\"), Blake Holdings Limited (\"BHL\"), Ora Ventures Limited (\"OVL\"), Ora Capital Limited (\"OCL), Sarossa Plc (\"SAR\"), Pinkeys Limited (\"PKL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL, BHL, OVL and OCL and the controlling shareholder of SAR and PKL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":7388660,"derivative":{"exercise_price":15.58,"underlying":"Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-26-095574","document":"tm2623118-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926095574/tm2623118-2_4seq1.xml","form_type":"4"}},{"id":687907,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-08-13T14:07:24.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":true,"shares":2792826,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\"), Blake Holdings Limited (\"BHL\"), Ora Ventures Limited (\"OVL\"), Ora Capital Limited (\"OCL), Sarossa Plc (\"SAR\"), Pinkeys Limited (\"PKL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL, BHL, OVL and OCL and the controlling shareholder of SAR and PKL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":7488660,"derivative":{"exercise_price":16,"underlying":"Ordinary Shares","underlying_shares":8378478},"source":{"system":"sec-edgar","filing":"0001104659-26-095574","document":"tm2623118-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926095574/tm2623118-2_4seq1.xml","form_type":"4"}},{"id":713593,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-07-07T13:09:40.000Z","date":"2026-07-06","kind":"sale","planned":false,"acquired":true,"shares":865112,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":10281486,"derivative":{"exercise_price":10.53,"underlying":"Ordinary Shares","underlying_shares":2595336},"source":{"system":"sec-edgar","filing":"0001104659-26-080997","document":"tm2619820-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926080997/tm2619820-1_4seq1.xml","form_type":"4"}},{"id":713592,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-07-07T13:09:40.000Z","date":"2026-07-02","kind":"sale","planned":false,"acquired":true,"shares":50082,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11146598,"derivative":{"exercise_price":10.47,"underlying":"Ordinary Shares","underlying_shares":150246},"source":{"system":"sec-edgar","filing":"0001104659-26-080997","document":"tm2619820-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926080997/tm2619820-1_4seq1.xml","form_type":"4"}},{"id":713591,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-07-07T13:09:40.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11196680,"derivative":{"exercise_price":10.62,"underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-26-080997","document":"tm2619820-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926080997/tm2619820-1_4seq1.xml","form_type":"4"}},{"id":713590,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-07-07T13:09:40.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":true,"shares":79180,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11246680,"derivative":{"exercise_price":10.62,"underlying":"Ordinary Shares","underlying_shares":237540},"source":{"system":"sec-edgar","filing":"0001104659-26-080997","document":"tm2619820-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926080997/tm2619820-1_4seq1.xml","form_type":"4"}},{"id":713589,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-07-07T13:09:40.000Z","date":"2026-06-30","kind":"sale","planned":false,"acquired":true,"shares":169928,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11325860,"derivative":{"exercise_price":10.76,"underlying":"Ordinary Shares","underlying_shares":509784},"source":{"system":"sec-edgar","filing":"0001104659-26-080997","document":"tm2619820-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926080997/tm2619820-1_4seq1.xml","form_type":"4"}},{"id":713588,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-07-07T13:09:40.000Z","date":"2026-06-29","kind":"sale","planned":false,"acquired":true,"shares":330072,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Cream Capital Limited (\"CCL\") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11495788,"derivative":{"exercise_price":10.69,"underlying":"Ordinary Shares","underlying_shares":990216},"source":{"system":"sec-edgar","filing":"0001104659-26-080997","document":"tm2619820-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926080997/tm2619820-1_4seq1.xml","form_type":"4"}},{"id":905102,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-02-13T11:02:01.000Z","date":"2025-10-27","kind":"purchase","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Ora Capital Limited (\"OCL\") and purchased by Mr. Griffiths personally, essentially internal transfers with no change in total beneficial holding. Mr Griffiths is a director and the controlling shareholder of OCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11825861,"derivative":{"exercise_price":7.75,"underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001104659-26-014603","document":"tm266179-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926014603/tm266179-1_4seq1.xml","form_type":"4"}},{"id":905101,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-02-13T11:02:01.000Z","date":"2025-10-27","kind":"sale","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Ora Capital Limited (\"OCL\") and purchased by Mr. Griffiths personally, essentially internal transfers with no change in total beneficial holding. Mr Griffiths is a director and the controlling shareholder of OCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11819861,"derivative":{"exercise_price":7.75,"underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001104659-26-014603","document":"tm266179-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926014603/tm266179-1_4seq1.xml","form_type":"4"}},{"id":905100,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-02-13T11:02:01.000Z","date":"2025-08-03","kind":"purchase","planned":false,"acquired":true,"shares":20000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Ora Capital Limited (\"OCL\") and purchased by Mr. Griffiths personally, essentially internal transfers with no change in total beneficial holding. Mr Griffiths is a director and the controlling shareholder of OCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11825861,"derivative":{"exercise_price":5.45,"underlying":"Ordinary Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-26-014603","document":"tm266179-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926014603/tm266179-1_4seq1.xml","form_type":"4"}},{"id":905099,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2026-02-13T11:02:01.000Z","date":"2025-08-03","kind":"sale","planned":false,"acquired":true,"shares":20000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities were sold by Ora Capital Limited (\"OCL\") and purchased by Mr. Griffiths personally, essentially internal transfers with no change in total beneficial holding. Mr Griffiths is a director and the controlling shareholder of OCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11805861,"derivative":{"exercise_price":5.45,"underlying":"Ordinary Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-26-014603","document":"tm266179-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465926014603/tm266179-1_4seq1.xml","form_type":"4"}},{"id":1076209,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-08-04T12:03:08.000Z","date":"2025-08-01","kind":"purchase","planned":false,"acquired":true,"shares":4034,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr. Griffiths is a director and the controlling shareholder of Cream. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11825861,"derivative":{"exercise_price":6.14,"underlying":"Ordinary Shares","underlying_shares":12102},"source":{"system":"sec-edgar","filing":"0001104659-25-073386","document":"tm2522470-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925073386/tm2522470-1_4seq1.xml","form_type":"4"}},{"id":1076208,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-08-04T12:03:08.000Z","date":"2025-07-31","kind":"purchase","planned":false,"acquired":true,"shares":14342,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr. Griffiths is a director and the controlling shareholder of Cream. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11821827,"derivative":{"exercise_price":6.18,"underlying":"Ordinary Shares","underlying_shares":43026},"source":{"system":"sec-edgar","filing":"0001104659-25-073386","document":"tm2522470-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925073386/tm2522470-1_4seq1.xml","form_type":"4"}},{"id":1078366,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-07-31T12:43:13.000Z","date":"2025-07-30","kind":"purchase","planned":false,"acquired":true,"shares":8923,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr. Griffiths is a director and the controlling shareholder of Cream. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11807485,"derivative":{"exercise_price":6.14,"underlying":"Ordinary Shares","underlying_shares":26769},"source":{"system":"sec-edgar","filing":"0001104659-25-072499","document":"tm2522205-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925072499/tm2522205-1_4seq1.xml","form_type":"4"}},{"id":1078365,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-07-31T12:43:13.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":14559,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr. Griffiths is a director and the controlling shareholder of Cream. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11798562,"derivative":{"exercise_price":6.2,"underlying":"Ordinary Shares","underlying_shares":43667},"source":{"system":"sec-edgar","filing":"0001104659-25-072499","document":"tm2522205-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925072499/tm2522205-1_4seq1.xml","form_type":"4"}},{"id":1082761,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-07-23T18:22:48.000Z","date":"2025-07-22","kind":"purchase","planned":false,"acquired":true,"shares":2910,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr. Griffiths is a director and the controlling shareholder of Cream. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11784003,"derivative":{"exercise_price":6.09,"underlying":"Ordinary Shares","underlying_shares":8730},"source":{"system":"sec-edgar","filing":"0001104659-25-069944","document":"tm2521554-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925069944/tm2521554-1_4seq1.xml","form_type":"4"}},{"id":1082760,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-07-23T18:22:48.000Z","date":"2025-07-21","kind":"purchase","planned":false,"acquired":true,"shares":22435,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr. Griffiths is a director and the controlling shareholder of Cream. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11781093,"derivative":{"exercise_price":6.04,"underlying":"Ordinary Shares","underlying_shares":67305},"source":{"system":"sec-edgar","filing":"0001104659-25-069944","document":"tm2521554-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925069944/tm2521554-1_4seq1.xml","form_type":"4"}},{"id":1086474,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-07-16T18:58:36.000Z","date":"2025-07-15","kind":"purchase","planned":false,"acquired":true,"shares":43293,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11758658,"derivative":{"exercise_price":6.4,"underlying":"Ordinary Shares","underlying_shares":129879},"source":{"system":"sec-edgar","filing":"0001104659-25-068309","document":"tm2521080-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925068309/tm2521080-1_4seq1.xml","form_type":"4"}},{"id":1086473,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-07-16T18:58:36.000Z","date":"2025-07-11","kind":"purchase","planned":false,"acquired":true,"shares":28000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11715365,"derivative":{"exercise_price":6.43,"underlying":"Ordinary Shares","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0001104659-25-068309","document":"tm2521080-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925068309/tm2521080-1_4seq1.xml","form_type":"4"}},{"id":1089286,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-07-10T12:36:47.000Z","date":"2025-07-09","kind":"purchase","planned":false,"acquired":true,"shares":30133,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11687365,"derivative":{"exercise_price":6,"underlying":"Ordinary Shares","underlying_shares":90399},"source":{"system":"sec-edgar","filing":"0001104659-25-066857","document":"tm2520411-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925066857/tm2520411-1_4seq1.xml","form_type":"4"}},{"id":1089285,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-07-10T12:36:47.000Z","date":"2025-07-08","kind":"purchase","planned":false,"acquired":true,"shares":24387,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11657232,"derivative":{"exercise_price":5.94,"underlying":"Ordinary Shares","underlying_shares":73161},"source":{"system":"sec-edgar","filing":"0001104659-25-066857","document":"tm2520411-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925066857/tm2520411-1_4seq1.xml","form_type":"4"}},{"id":1089284,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-07-10T12:36:47.000Z","date":"2025-07-07","kind":"purchase","planned":false,"acquired":true,"shares":7937,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11632845,"derivative":{"exercise_price":5.65,"underlying":"Ordinary Shares","underlying_shares":23811},"source":{"system":"sec-edgar","filing":"0001104659-25-066857","document":"tm2520411-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925066857/tm2520411-1_4seq1.xml","form_type":"4"}},{"id":1099226,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-06-30T16:31:34.000Z","date":"2025-06-27","kind":"purchase","planned":false,"acquired":true,"shares":24000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11624908,"derivative":{"exercise_price":5.82,"underlying":"Ordinary Shares","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001104659-25-063969","document":"tm2519448-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925063969/tm2519448-1_4seq1.xml","form_type":"4"}},{"id":1099225,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-06-30T16:31:34.000Z","date":"2025-06-26","kind":"purchase","planned":false,"acquired":true,"shares":20735,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11600908,"derivative":{"exercise_price":5.67,"underlying":"Ordinary Shares","underlying_shares":62205},"source":{"system":"sec-edgar","filing":"0001104659-25-063969","document":"tm2519448-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925063969/tm2519448-1_4seq1.xml","form_type":"4"}},{"id":1099224,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-06-30T16:31:34.000Z","date":"2025-06-26","kind":"purchase","planned":false,"acquired":true,"shares":65739,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11580173,"derivative":{"exercise_price":5.91,"underlying":"Ordinary Shares","underlying_shares":197217},"source":{"system":"sec-edgar","filing":"0001104659-25-063969","document":"tm2519448-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925063969/tm2519448-1_4seq1.xml","form_type":"4"}},{"id":1101679,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-06-25T12:59:53.000Z","date":"2025-06-24","kind":"purchase","planned":false,"acquired":true,"shares":26624,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11514434,"derivative":{"exercise_price":6.12,"underlying":"Ordinary Shares","underlying_shares":79872},"source":{"system":"sec-edgar","filing":"0001104659-25-062407","document":"tm2518943-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925062407/tm2518943-1_4seq1.xml","form_type":"4"}},{"id":1101678,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-06-25T12:59:53.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":true,"shares":35005,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11487810,"derivative":{"exercise_price":5.88,"underlying":"Ordinary Shares","underlying_shares":105015},"source":{"system":"sec-edgar","filing":"0001104659-25-062407","document":"tm2518943-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925062407/tm2518943-1_4seq1.xml","form_type":"4"}},{"id":1101677,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-06-25T12:59:53.000Z","date":"2025-06-22","kind":"purchase","planned":false,"acquired":true,"shares":20977,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11452805,"derivative":{"exercise_price":5.84,"underlying":"Ordinary Shares","underlying_shares":62931},"source":{"system":"sec-edgar","filing":"0001104659-25-062407","document":"tm2518943-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925062407/tm2518943-1_4seq1.xml","form_type":"4"}},{"id":1104955,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-06-20T10:46:02.000Z","date":"2025-06-18","kind":"purchase","planned":false,"acquired":true,"shares":39049,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11431828,"derivative":{"exercise_price":5.69,"underlying":"Ordinary Shares","underlying_shares":117147},"source":{"system":"sec-edgar","filing":"0001104659-25-060862","document":"tm2518525-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925060862/tm2518525-1_4seq1.xml","form_type":"4"}},{"id":1104954,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-06-20T10:46:02.000Z","date":"2025-06-17","kind":"purchase","planned":false,"acquired":true,"shares":31399,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11392779,"derivative":{"exercise_price":5.29,"underlying":"Ordinary Shares","underlying_shares":94197},"source":{"system":"sec-edgar","filing":"0001104659-25-060862","document":"tm2518525-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925060862/tm2518525-1_4seq1.xml","form_type":"4"}},{"id":1111554,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-06-13T12:06:49.000Z","date":"2025-06-12","kind":"purchase","planned":false,"acquired":true,"shares":39305,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11361380,"derivative":{"exercise_price":5.15,"underlying":"Ordinary Shares","underlying_shares":117915},"source":{"system":"sec-edgar","filing":"0001104659-25-059168","document":"tm2517968-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925059168/tm2517968-1_4seq1.xml","form_type":"4"}},{"id":1130507,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-29T15:21:29.000Z","date":"2025-05-28","kind":"purchase","planned":false,"acquired":true,"shares":9169,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11322075,"derivative":{"exercise_price":5.11,"underlying":"Ordinary Shares","underlying_shares":27507},"source":{"system":"sec-edgar","filing":"0001104659-25-054045","document":"tm2516482-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925054045/tm2516482-1_4seq1.xml","form_type":"4"}},{"id":1130506,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-29T15:21:29.000Z","date":"2025-05-27","kind":"purchase","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11312906,"derivative":{"exercise_price":5.13,"underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-25-054045","document":"tm2516482-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925054045/tm2516482-1_4seq1.xml","form_type":"4"}},{"id":1130505,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-29T15:21:29.000Z","date":"2025-05-26","kind":"purchase","planned":false,"acquired":true,"shares":26669,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11262906,"derivative":{"exercise_price":4.91,"underlying":"Ordinary Shares","underlying_shares":80007},"source":{"system":"sec-edgar","filing":"0001104659-25-054045","document":"tm2516482-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925054045/tm2516482-1_4seq1.xml","form_type":"4"}},{"id":1133334,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-27T12:35:18.000Z","date":"2025-05-23","kind":"purchase","planned":false,"acquired":true,"shares":17187,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11236237,"derivative":{"exercise_price":4.92,"underlying":"Ordinary Shares","underlying_shares":51561},"source":{"system":"sec-edgar","filing":"0001104659-25-052749","document":"tm2516192-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925052749/tm2516192-1_4seq1.xml","form_type":"4"}},{"id":1133333,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-27T12:35:18.000Z","date":"2025-05-22","kind":"purchase","planned":false,"acquired":true,"shares":19174,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11219050,"derivative":{"exercise_price":5.04,"underlying":"Ordinary Shares","underlying_shares":57522},"source":{"system":"sec-edgar","filing":"0001104659-25-052749","document":"tm2516192-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925052749/tm2516192-1_4seq1.xml","form_type":"4"}},{"id":1138940,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-21T10:49:38.000Z","date":"2025-05-20","kind":"purchase","planned":false,"acquired":true,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11199876,"derivative":{"exercise_price":4.07,"underlying":"Ordinary Shares","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001104659-25-051284","document":"tm2515795-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925051284/tm2515795-1_4seq1.xml","form_type":"4"}},{"id":1138939,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-21T10:49:38.000Z","date":"2025-05-19","kind":"purchase","planned":false,"acquired":true,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11183876,"derivative":{"exercise_price":4.07,"underlying":"Ordinary Shares","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0001104659-25-051284","document":"tm2515795-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925051284/tm2515795-1_4seq1.xml","form_type":"4"}},{"id":1138938,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-21T10:49:38.000Z","date":"2025-05-18","kind":"purchase","planned":false,"acquired":true,"shares":37023,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11157876,"derivative":{"exercise_price":4.01,"underlying":"Ordinary Shares","underlying_shares":111069},"source":{"system":"sec-edgar","filing":"0001104659-25-051284","document":"tm2515795-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925051284/tm2515795-1_4seq1.xml","form_type":"4"}},{"id":1147298,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-15T20:51:57.000Z","date":"2025-05-14","kind":"purchase","planned":false,"acquired":true,"shares":55766,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11120853,"derivative":{"exercise_price":4.07,"underlying":"Ordinary Shares","underlying_shares":167298},"source":{"system":"sec-edgar","filing":"0001104659-25-049572","document":"tm2515252-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925049572/tm2515252-1_4seq1.xml","form_type":"4"}},{"id":1147297,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-15T20:51:57.000Z","date":"2025-05-13","kind":"purchase","planned":false,"acquired":true,"shares":94234,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":11065087,"derivative":{"exercise_price":4.01,"underlying":"Ordinary Shares","underlying_shares":282702},"source":{"system":"sec-edgar","filing":"0001104659-25-049572","document":"tm2515252-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925049572/tm2515252-1_4seq1.xml","form_type":"4"}},{"id":1155031,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-08T11:08:00.000Z","date":"2025-05-07","kind":"purchase","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10970853,"derivative":{"exercise_price":3.81,"underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-25-045874","document":"tm2514463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925045874/tm2514463-1_4seq1.xml","form_type":"4"}},{"id":1155030,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-08T11:08:00.000Z","date":"2025-05-06","kind":"purchase","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10920850,"derivative":{"exercise_price":3.96,"underlying":"Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-25-045874","document":"tm2514463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925045874/tm2514463-1_4seq1.xml","form_type":"4"}},{"id":1155029,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-08T11:08:00.000Z","date":"2025-05-05","kind":"purchase","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10820853,"derivative":{"exercise_price":3.94,"underlying":"Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-25-045874","document":"tm2514463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925045874/tm2514463-1_4seq1.xml","form_type":"4"}},{"id":1161119,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-02T14:28:34.000Z","date":"2025-05-01","kind":"purchase","planned":false,"acquired":true,"shares":75266,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10720853,"derivative":{"exercise_price":3.97,"underlying":"Ordinary Shares","underlying_shares":225798},"source":{"system":"sec-edgar","filing":"0001104659-25-043878","document":"tm2513902-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925043878/tm2513902-1_4seq1.xml","form_type":"4"}},{"id":1161118,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-05-02T14:28:34.000Z","date":"2025-04-30","kind":"purchase","planned":false,"acquired":true,"shares":34309,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10645587,"derivative":{"exercise_price":3.66,"underlying":"Ordinary Shares","underlying_shares":102927},"source":{"system":"sec-edgar","filing":"0001104659-25-043878","document":"tm2513902-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925043878/tm2513902-1_4seq1.xml","form_type":"4"}},{"id":1163339,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-30T11:13:20.000Z","date":"2025-04-29","kind":"purchase","planned":false,"acquired":true,"shares":54768,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10611278,"derivative":{"exercise_price":3.49,"underlying":"Ordinary Shares","underlying_shares":164304},"source":{"system":"sec-edgar","filing":"0001104659-25-041787","document":"tm2513649-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925041787/tm2513649-1_4seq1.xml","form_type":"4"}},{"id":1163338,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-30T11:13:20.000Z","date":"2025-04-28","kind":"purchase","planned":false,"acquired":true,"shares":95211,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10556510,"derivative":{"exercise_price":3.43,"underlying":"Ordinary Shares","underlying_shares":285633},"source":{"system":"sec-edgar","filing":"0001104659-25-041787","document":"tm2513649-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925041787/tm2513649-1_4seq1.xml","form_type":"4"}},{"id":1164855,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-28T10:50:03.000Z","date":"2025-04-25","kind":"purchase","planned":false,"acquired":true,"shares":59568,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10461299,"derivative":{"exercise_price":3.54,"underlying":"Ordinary Shares","underlying_shares":178704},"source":{"system":"sec-edgar","filing":"0001104659-25-039744","document":"tm2513337-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925039744/tm2513337-1_4seq1.xml","form_type":"4"}},{"id":1164854,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-28T10:50:03.000Z","date":"2025-04-24","kind":"purchase","planned":false,"acquired":true,"shares":90432,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10401731,"derivative":{"exercise_price":3.42,"underlying":"Ordinary Shares","underlying_shares":271296},"source":{"system":"sec-edgar","filing":"0001104659-25-039744","document":"tm2513337-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925039744/tm2513337-1_4seq1.xml","form_type":"4"}},{"id":1166382,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-24T11:16:25.000Z","date":"2025-04-23","kind":"purchase","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10311299,"derivative":{"exercise_price":3.18,"underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-25-038340","document":"tm2513097-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925038340/tm2513097-1_4seq1.xml","form_type":"4"}},{"id":1166381,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-24T11:16:25.000Z","date":"2025-04-22","kind":"purchase","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10261299,"derivative":{"exercise_price":3.1,"underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-25-038340","document":"tm2513097-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925038340/tm2513097-1_4seq1.xml","form_type":"4"}},{"id":1167711,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-22T14:35:32.000Z","date":"2025-04-21","kind":"purchase","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10211299,"derivative":{"exercise_price":3.12,"underlying":"Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-25-037215","document":"tm2512870-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925037215/tm2512870-1_4seq1.xml","form_type":"4"}},{"id":1167710,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-22T14:35:32.000Z","date":"2025-04-17","kind":"purchase","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10111299,"derivative":{"exercise_price":3.14,"underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-25-037215","document":"tm2512870-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925037215/tm2512870-1_4seq1.xml","form_type":"4"}},{"id":1171769,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-15T18:17:20.000Z","date":"2025-04-15","kind":"purchase","planned":false,"acquired":true,"shares":27918,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10061299,"derivative":{"exercise_price":2.78,"underlying":"Ordinary Shares","underlying_shares":83754},"source":{"system":"sec-edgar","filing":"0001104659-25-035039","document":"tm2512383-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925035039/tm2512383-1_4seq1.xml","form_type":"4"}},{"id":1171768,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-15T18:17:20.000Z","date":"2025-04-14","kind":"purchase","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":10033381,"derivative":{"exercise_price":2.65,"underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-25-035039","document":"tm2512383-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925035039/tm2512383-1_4seq1.xml","form_type":"4"}},{"id":1171767,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-15T18:17:20.000Z","date":"2025-04-14","kind":"purchase","planned":false,"acquired":true,"shares":40409,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":9983381,"derivative":{"exercise_price":2.71,"underlying":"Ordinary Shares","underlying_shares":121227},"source":{"system":"sec-edgar","filing":"0001104659-25-035039","document":"tm2512383-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925035039/tm2512383-1_4seq1.xml","form_type":"4"}},{"id":1171766,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-15T18:17:20.000Z","date":"2025-04-11","kind":"purchase","planned":false,"acquired":true,"shares":56480,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":9942972,"derivative":{"exercise_price":2.33,"underlying":"Ordinary Shares","underlying_shares":169440},"source":{"system":"sec-edgar","filing":"0001104659-25-035039","document":"tm2512383-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925035039/tm2512383-1_4seq1.xml","form_type":"4"}},{"id":1171765,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-15T18:17:20.000Z","date":"2025-04-10","kind":"purchase","planned":false,"acquired":true,"shares":25193,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":9886492,"derivative":{"exercise_price":2.14,"underlying":"Ordinary Shares","underlying_shares":75579},"source":{"system":"sec-edgar","filing":"0001104659-25-035039","document":"tm2512383-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925035039/tm2512383-1_4seq1.xml","form_type":"4"}},{"id":1186374,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-04-01T11:50:55.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":false,"nature":"By Cream Capital Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities transactions listed were made by Cream Capital Limited (\"Cream\"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":9861299,"derivative":{"exercise_price":2.83,"underlying":"Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-25-030241","document":"tm2511054-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925030241/tm2511054-1_4seq1.xml","form_type":"4"}},{"id":1187836,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-03-31T14:47:52.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":false,"nature":"By Cream Capital Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities transactions listed were made by Cream Capital Limited (\"Cream\"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":9761299,"derivative":{"exercise_price":3.46,"underlying":"Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-25-029715","document":"tm2510904-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925029715/tm2510904-1_4seq1.xml","form_type":"4"}},{"id":1187835,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-03-31T14:47:52.000Z","date":"2025-03-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":false,"nature":"By Cream Capital Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities transactions listed were made by Cream Capital Limited (\"Cream\"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":9661299,"derivative":{"exercise_price":3.58,"underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-25-029715","document":"tm2510904-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925029715/tm2510904-1_4seq1.xml","form_type":"4"}},{"id":1187834,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-03-31T14:47:52.000Z","date":"2025-03-27","kind":"purchase","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":false,"nature":"By Cream Capital Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities transactions listed were made by Cream Capital Limited (\"Cream\"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":9611299,"derivative":{"exercise_price":3.32,"underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-25-029715","document":"tm2510904-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925029715/tm2510904-1_4seq1.xml","form_type":"4"}},{"id":1219474,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-03-06T16:03:13.000Z","date":"2025-03-05","kind":"purchase","planned":false,"acquired":true,"shares":22632,"ownership":{"direct":false,"nature":"By Cream Capital Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":9561299,"derivative":{"exercise_price":4.5,"underlying":"Ordinary Shares","underlying_shares":67896},"source":{"system":"sec-edgar","filing":"0001104659-25-021245","document":"tm258471-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925021245/tm258471-1_4seq1.xml","form_type":"4"}},{"id":1246000,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-02-25T15:59:52.000Z","date":"2025-02-18","kind":"purchase","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":9538667,"derivative":{"exercise_price":4.85,"underlying":"Ordinary Shares","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001104659-25-016802","document":"tm257556-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925016802/tm257556-1_4seq1.xml","form_type":"4"}},{"id":1245999,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-02-25T15:59:52.000Z","date":"2025-02-13","kind":"purchase","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":9478667,"derivative":{"exercise_price":4.17,"underlying":"Ordinary Shares","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001104659-25-016802","document":"tm257556-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925016802/tm257556-1_4seq1.xml","form_type":"4"}},{"id":1245998,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-02-25T15:59:52.000Z","date":"2025-02-13","kind":"purchase","planned":false,"acquired":true,"shares":92774,"ownership":{"direct":false,"nature":"By Cream Capital Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":9418667,"derivative":{"exercise_price":4.29,"underlying":"Ordinary Shares","underlying_shares":278322},"source":{"system":"sec-edgar","filing":"0001104659-25-016802","document":"tm257556-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925016802/tm257556-1_4seq1.xml","form_type":"4"}},{"id":1245997,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-02-25T15:59:52.000Z","date":"2025-01-23","kind":"purchase","planned":false,"acquired":true,"shares":12226,"ownership":{"direct":false,"nature":"By Cream Capital Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":9325893,"derivative":{"exercise_price":5.35,"underlying":"Ordinary Shares","underlying_shares":36678},"source":{"system":"sec-edgar","filing":"0001104659-25-016802","document":"tm257556-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925016802/tm257556-1_4seq1.xml","form_type":"4"}},{"id":1245996,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-02-25T15:59:52.000Z","date":"2025-01-21","kind":"purchase","planned":false,"acquired":true,"shares":20000,"ownership":{"direct":false,"nature":"By Cream Capital Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":9313667,"derivative":{"exercise_price":5.48,"underlying":"Ordinary Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-25-016802","document":"tm257556-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925016802/tm257556-1_4seq1.xml","form_type":"4"}},{"id":1245995,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-02-25T15:59:52.000Z","date":"2025-01-21","kind":"purchase","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":false,"nature":"By Cream Capital Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":9293667,"derivative":{"exercise_price":5.2,"underlying":"Ordinary Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-25-016802","document":"tm257556-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925016802/tm257556-1_4seq1.xml","form_type":"4"}},{"id":1245994,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-02-25T15:59:52.000Z","date":"2025-01-17","kind":"purchase","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":false,"nature":"By Cream Capital Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Cream Capital Limited (\"Cream\"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein."}],"balance_after":9268667,"derivative":{"exercise_price":5.35,"underlying":"Ordinary Shares","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001104659-25-016802","document":"tm257556-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925016802/tm257556-1_4seq1.xml","form_type":"4"}},{"id":1245993,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":23693,"kind":"person","name":"Griffiths Richard Ian","position":1,"cik":"0001846370","reported_name":"Griffiths Richard Ian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depositary Shares","published_at":"2025-02-25T15:59:52.000Z","date":"2025-01-08","kind":"purchase","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each American Depositary Share (\"ADS\") is immediately convertible into three ordinary shares for no consideration and has no expiration date."}],"balance_after":9118667,"derivative":{"exercise_price":6.48,"underlying":"Ordinary Shares","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001104659-25-016802","document":"tm257556-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000110465925016802/tm257556-1_4seq1.xml","form_type":"4"}}]}